DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2460522
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2460522
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 19, 2024 | Celgene | POMALYST | pomalidomide |
➤ Sign Up | Jun 17, 2025 | Celgene | POMALYST | pomalidomide |
➤ Sign Up | May 15, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | May 15, 2023 | Celgene | POMALYST | pomalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |